University accolade for Christie clinicians

Press release posted 28 June 2019

Senior clinicians from The Christie NHS Foundation Trust have been honoured with prestigious promotions from The University of Manchester.

Dr Emma Crosbie and Dr Fiona Thistlethwaite have both been awarded Honorary Academic Chairs and will become professors as recognition for being international leaders in their field of expertise.

Dr Crosbie is a consultant gynaecological cancer surgeon whose research interests include screening, prevention and the early detection of gynaecological cancers, as well as developing new treatments and interventions for women with established disease.

Dr Thistlethwaite is a medical oncology consultant within the experimental cancer medicines team at The Christie. Her clinical practice is in experimental cancer medicine and immune-oncology and her academic focus is clinical trial development in immunotherapy and adoptive T-cell therapy.

Meanwhile Dr Adrian Bloor, Dr Julia Handley and Dr Was Mansoor have been honoured with a Manchester Academic Health Science Centre (MAHSC) Honorary Clinical Chair by The University of Manchester. The MAHSC chairs, which were initiated six years ago, recognise those individuals who have made a major contribution to their clinical speciality.

Dr Bloor is a consultant haematologist. He has an expertise in management of a wide range of haematological malignancies (lymphoma, leukaemia and myeloma) with a special interest in the management of lymphoid malignancies (CLL and lymphoma), stem cell transplantation and in clinical trials.

Dr Julie Handley is a consultant clinical scientists and is head of radiotherapy physics at The Christie.

Dr Mansoor is a consultant in medical oncology. He is the clinical director of medical oncology and specialises in treating upper gastrointestinal cancer.

Professors usually work within hospitals and hold an honorary position at The University of Manchester. Honorary Clinical Chairs are awarded on an annual basis by the university’s Faculty of Medical and Human Sciences Promotions Committee.

Professor Chris Harrison, Executive Medical Director at The Christie, said: “We are delighted our leading clinicians who are international experts in their field have been recognized by The University of Manchester. They exemplify the drive for improvement and excellence which underpins The Christie’s status as one of the leading hospitals in the world for cancer treatment and research.”

The Christie NHS Foundation Trust was the first specialist trust to be rated as ‘Outstanding’ twice (in 2016 and 2018) by the health regulator the Care Quality Commission (CQC). It referred to The Christie as ‘a leader in cancer care’ and ‘a pioneer in developing innovative solutions to cancer care.’ The CQC praised the Trust’s staff which it said ‘go the extra mile to meet the needs of patients and their families’ and that they were ‘exceptionally kind and caring.’ In 2017, the CQC rated The Christie as the best specialist trust in the country, and one of the top three trusts overall in England.